U.S. loses measles elimination status

An international health organization has determined that the United States has lost its measles elimination status, according to multiple news reports. Why it matters: It's an official recognition of how much the country's public health has deteriorated due to a rolling series of outbreaks since early last year. Increased public skepticism about the safety and effectiveness of vaccines, a barrage of distrust from federal officials like Health Secretary Robert F. Kennedy Jr. and funding cuts for response efforts have all factored in the surge of cases, according to public health experts. The big picture: The Pan American Health Organization concluded there has been sustained transmission of the highly contagious virus for longer than 12 months, bringing the U.S. case count to its highest level in 35 years. The measles elimination status hinges on whether the same strain of measles stays in circulation for 12 months or longer without a break. The overwhelming majority of cases are in unvaccinated people. While overall measles vaccination rates remain relatively high, public health officials say they have to remain above 95% to maintain herd immunity. Driving the news: An expert panel convened by the Pan American Health Organization made the widely expected decision following a three-day meeting in Washington, D.C. What they're saying: "It is no surprise that the resurgence of measles has coincided with an administration that has inflicted significant damage to our health care system while spreading false claims about vaccines," said Richard Besser, president and CEO of the Robert Wood Johnson Foundation and a former acting director of the Centers for Disease Control. "It is unthinkable that people in the United States should be dying from measles in 2026," the Infectious Diseases Society said in comments prior to the decision. The group cited the potential long-term toll on infants infected this year, some of whom could develop serious neurologic disease years after t
Read the full story at Axios →